Sponsored by
The FDA has approved a new safety warning for the birth control shot Depo-Provera, adding label language about a possible increased risk of meningioma. The update follows growing evidence, similar warnings already issued in Europe and Canada, and comes amid lawsuits alleging Pfizer failed to warn patients of the potential risk earlier. Depo-Provera is widely used in the U.S., making this an important development for patient awareness and informed decision-making.